Print

IAVI N004 HIV-CORE 004

A Phase I/IIa Clinical Trial of HIV-1 Vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and Ad35-GRIN in Combined Regimens in Healthy HIV-1/2-negative Adults in Nairobi.

Trial Details:

I/II Completed
University of Oxford, European and Developing Countries Clinical Trials Partnership, IAVI, Ichor, Karolinska March 31, 2014
Ad35-GRIN,MVA.HIVconsv,pSG2.HIVconsv MVA consensus; DNA consensus; Ad35 Gag, RT, Integ, Nef A
Ad35-GRIN Viral Vector - Adeno
MVA.HIVconsv Viral Vector - Pox
pSG2.HIVconsv DNA
pSG2.HIVconsv DNA
Kenya 72
NCT02099994
http://www.clinicaltrials.gov/ct2/show/NCT02099994?term=hiv+and+vaccine&lup_s=03%2F17%2F2014&lup_d=14&show_rss=Y&sel_rss=mod14